Tenidap

N/A

Report date: 2022/05/16 18:00:17

NME

Base Information

Drug NameTenidap

Drug Alias Name替尼达帕CP-66248CP-66248-2

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclooxygenases inhibitors

TargetsCyclooxygenases

Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (NDA/BLA)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsOsteoarthritisArthritis, Rheumatoid

ATC CodeM01AX23